Description

7-Chloro-6-Methyl-3A,4,5,9B-Tetrahydro-3H-Cyclopenta[C]Quinoline-4-Carboxylic Acid is a high-purity, advanced pharmaceutical intermediate with a complex polycyclic structure. This compound is of significant value in the research and development of novel therapeutic agents, particularly within the fields of central nervous system (CNS) and anti-inflammatory drug discovery. It is primarily sought after by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers engaged in synthesizing complex bioactive molecules.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel quinoline-based drug candidates.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to develop new therapeutic compounds.
• CNS Drug Development: Serves as a precursor for potential agents targeting neurological disorders.
• Anti-inflammatory Agent Synthesis: A critical intermediate in the development of new anti-inflammatory pharmaceuticals.
• Contract Manufacturing: Supplied to CDMOs for the production of clinical trial materials and niche APIs.
• Academic Research: Utilized in university and institutional labs for pharmacological and chemical research.

Basic Information

Product Name	7-Chloro-6-Methyl-3A,4,5,9B-Tetrahydro-3H-Cyclopenta[C]Quinoline-4-Carboxylic Acid
CAS No.	312713-96-5
Molecular Formula	C15H14ClNO2
Molecular Weight	275.73 g/mol
Synonyms	7-Chloro-6-methyl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-4-carboxylic acid; 4-Cyclopenta[c]quinolinecarboxylic acid, 3a,4,5,9b-tetrahydro-7-chloro-6-methyl-3H-; 312713-96-5; 7-Chloro-6-methyl-1,2,3,3a,4,9b-hexahydrocyclopenta[c]quinoline-4-carboxylic acid; UNII-8Q6T3F7U8H; 8Q6T3F7U8H; SCHEMBL2180241.
EINECS	Contact for details

Quality Control

Our 7-Chloro-6-Methyl-3A,4,5,9B-Tetrahydro-3H-Cyclopenta[C]Quinoline-4-Carboxylic Acid is manufactured under strict quality systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with every shipment, detailing all critical quality attributes. Our commitment to quality supports compliance with cGMP and ICH guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Keep away from incompatible materials such as strong oxidizing agents. For long-term storage, consider storing under an inert atmosphere to maintain stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Any single impurity	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.